BYAH DEADLINE: SueWallSt Reminds Park Ha Biological Technology Co., Ltd. Investors of Upcoming Securities Class Action Deadline

Notice to Pension Funds, Asset Managers, and Fiduciaries: BYAH's July 8, 2025 single-session collapse erased more than $1 billion in market capitalization, and the lawsuit contends the Company's sub-5% public float structure left institutional holders exposed to alleged manipulation that was never disclosed.

NEW YORK, Aug. 27, 2026 /PRNewswire/ -- SueWallSt notifies institutional investors in Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) that a class action has been filed on behalf of shareholders who purchased securities between December 27, 2024 and July 8, 2025. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at [email protected] or (888) SueWallSt.

BYAH shares fell approximately 93% on July 8, 2025, closing at $2.99 after a prior close of $41.01, a single-session decline of roughly $38.02 per share that wiped out more than $1 billion in market capitalization. To be considered for lead plaintiff, investors must file by September 28, 2026.

Notice to Institutional Holders

The pleading asserts that the Company's public statements and risk disclosures omitted that BYAH securities were the vehicle for a coordinated promotional scheme, and that the offering was structured so that a public float of less than 5% of outstanding shares could be moved dramatically by modest buying pressure. For funds holding BYAH through small-cap, emerging-markets, or China-focused mandates, the alleged omissions bear directly on position sizing, liquidity assumptions, and valuation models built on disclosed risk factors.

"Institutional investors play a critical role in securities class actions, and in a case where the complaint alleges that the disclosed float structure itself enabled the alleged manipulation, fiduciaries holding BYAH may wish to review how those alleged omissions affected their valuation and liquidity assumptions." -- Joseph E. Levi, Esq.

Fiduciary Obligations and Recovery Options

• Trustees and investment committees generally have a duty to identify, evaluate, and pursue recoverable claims held as plan assets, which may include securities litigation claims.
• Institutions with the largest documented losses are typically best positioned for court appointment as lead plaintiff.
• Lead plaintiff appointment provides direct oversight of counsel, litigation strategy, and settlement decisions without increasing an individual claimant's recovery.
• Institutions that take no action before the deadline may still participate in any eventual recovery as absent class members.
• Custodial and transaction-level records are ordinarily sufficient to support a loss analysis, and the review is provided at no cost and no obligation.
• Institutions that sold their BYAH position at a loss may still be eligible based on Class Period purchase dates.

Portfolio Impact Assessment

The action charges that a company reporting 39 franchisees and $551,970 in franchise fee revenue for the six months ended April 30, 2024 carried a market capitalization exceeding $1 billion by July 7, 2025, roughly six months after an offering that raised approximately $4.8 million at an implied enterprise valuation near $96 million. The complaint contends that no material corporate development supported that valuation and that investors were not told what allegedly did.

Contact us to learn more about institutional recovery options or call (888) SueWallSt.

WHY SUEWALLST: SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

Frequently Asked Questions About the BYAH Lawsuit

Q: What specific misstatements does the BYAH lawsuit allege? A: The complaint alleges Park Ha Biological Technology Co., Ltd. made materially false or misleading statements regarding the true nature of its securities trading activity, including omitting that the stock was allegedly the subject of a social media promotional scheme and that the offering was structured with an extremely low public float. When the artificial price surge collapsed, the stock price declined sharply.

Q: When did Park Ha Biological Technology Co., Ltd. allegedly mislead investors? A: The Class Period runs from December 27, 2024 to July 8, 2025. The complaint alleges that corrective disclosures revealed information that caused a significant stock decline.

Q: What court was the BYAH class action filed in? A: The case was filed in the United States District Court for the Southern District of New York, governed by the Private Securities Litigation Reform Act of 1995.

Q: What is a lead plaintiff and why does it matter? A: A lead plaintiff is the investor appointed by the court to represent the entire class. Lead plaintiffs are typically investors with the largest documented losses. Being appointed does not increase individual recovery but gives direct oversight of how the case is run.

Q: What do BYAH investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact SueWallSt, a brand of Levi & Korsinsky LLP, for a no-cost, no-obligation evaluation at [email protected] or (212) 363-7500. No immediate action is required to remain eligible to participate in the investigation.

Q: What does it cost me to participate? A: There is no upfront cost to contact the firm. Securities class actions are generally handled on a pure contingency basis. No upfront fees, no retainer, and no out-of-pocket costs. Any attorneys' fees and expenses awarded to class counsel are subject to court approval.

Q: What if I live outside the United States? A: U.S. securities class actions generally cover purchases on U.S. exchanges regardless of the investor's country of residence.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (888) SueWallSt
Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

SOURCE SueWallSt.com